1
|
Murray B, Athale J, Balk RA, Behal ML, Brown JE, Chanas T, Dumitru R, Gifford DC, Hohlfelder B, Jones HM, Makic MBF, Rausen MS, Sacco AJ, Sines BJ, Gurnani PK. Major Publications in the Critical Care Pharmacotherapy Literature: 2023. Crit Care Explor 2024; 6:e1162. [PMID: 39360775 PMCID: PMC11452093 DOI: 10.1097/cce.0000000000001162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/06/2024] Open
Abstract
OBJECTIVES We aimed to summarize the most significant and impactful publications describing the pharmacotherapeutic care of critically ill patients in 2023. DATA SOURCES PubMed/MEDLINE and the Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update. STUDY SELECTION Randomized controlled trials and prospective studies of adult critically ill patients assessing a pharmacotherapeutic intervention and reporting clinical endpoints published between January 1, 2023, and December 31, 2023, were eligible for inclusion in this article. DATA EXTRACTION Articles from a systematic search and the Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update were included. An a priori defined three-round modified Delphi process was employed to achieve consensus on the most impactful publications based on the following considerations: 1) overall contribution to scientific knowledge and 2) novelty to the literature. DATA SYNTHESIS The systematic search and Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update returned a total of 1202 articles, of which 1164 were excluded. The remaining 38 articles underwent a three-round modified Delphi process. In each round, articles were independently scored based on overall contribution to scientific knowledge and novelty to the literature. Included articles are summarized and their impact discussed. Article topics included hydrocortisone for severe community-acquired pneumonia, inhaled amikacin for prevention of ventilator-associated pneumonia, methylene blue for septic shock, restrictive vs. liberal fluid management for sepsis-induced hypotension, andexanet alfa for major bleeding associated with factor Xa inhibitors, and early administration of four-factor prothrombin complex concentrate in patients with trauma at risk for massive transfusion. CONCLUSIONS This review provides a summary and perspective on the potential impact of the most relevant articles in 2023 describing advances in the pharmacotherapeutic care of critically ill patients.
Collapse
Affiliation(s)
- Brian Murray
- Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO
| | - Janhavi Athale
- Department of Critical Care, Mayo Clinic Arizona, Phoenix, AZ
| | - Robert A. Balk
- Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Rush Medical College and Rush University Medical Center, Chicago, IL
| | - Michael L. Behal
- Department of Pharmacy, University of Tennessee Medical Center, Knoxville, TN
| | - Judah E. Brown
- Department of Pharmacy, NewYork Presbyterian Hospital/Columbia University Irving Medical Center, New York, NY
| | - Tyler Chanas
- Department of Pharmacy, ECU Health Medical Center, Greenville, NC
| | - Roxana Dumitru
- Department of Pharmacy, NewYork Presbyterian Hospital/Columbia University Irving Medical Center, New York, NY
| | - Dalton C. Gifford
- Department of Vascular and Interventional Radiology, University of Kentucky, Lexington, KY
| | | | - Honey M. Jones
- Department of Medicine, Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina Medical Center, Chapel Hill, NC
| | - Mary Beth F. Makic
- University of Colorado Anschutz Medical Campus, College of Nursing, Aurora, CO
| | - Michelle S. Rausen
- Department of Respiratory Therapy, Memorial Sloan Kettering Cancer Center, New York, NY
| | | | - Benjamin J. Sines
- Department of Medicine, Division of Pulmonary Diseases and Critical Care Medicine, University of North Carlina at Chapel Hill, Chapel Hill, NC
| | | |
Collapse
|
2
|
Gurnani PK, Barlow B, Boling B, Busse LW, Diaz-Gomez JL, Ford J, Gibson GA, Khanna AK, Lee JS, Rivosecchi RM, Spezzano KM, Thornton N, Vallabhajosyula S, Witenko CJ, Wieruszewski PM. Major Publications in the Critical Care Pharmacotherapy Literature: 2022. Crit Care Explor 2023; 5:e0981. [PMID: 37753239 PMCID: PMC10519466 DOI: 10.1097/cce.0000000000000981] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/28/2023] Open
Abstract
OBJECTIVES A number of trials related to critical care pharmacotherapy were published in 2022. We aimed to summarize the most influential publications related to the pharmacotherapeutic care of critically ill patients in 2022. DATA SOURCES PubMed/Medical Literature Analysis and Retrieval System Online and the Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update. STUDY SELECTION Randomized controlled trials, prospective studies, or systematic review/meta-analyses of adult critically ill patients assessing a pharmacotherapeutic intervention and reporting clinical endpoints published between January 1, 2022, and December 31, 2022, were included in this article. DATA EXTRACTION Articles from a systematic search and the Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update were included and stratified into clinical domains based upon consistent themes. Consensus was obtained on the most influential publication within each clinical domain utilizing an a priori defined three-round modified Delphi process with the following considerations: 1) overall contribution to scientific knowledge and 2) novelty to the literature. DATA SYNTHESIS The systematic search and Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update yielded a total of 704 articles, of which 660 were excluded. The remaining 44 articles were stratified into the following clinical domains: emergency/neurology, cardiovascular, gastroenterology/fluids/nutrition, hematology, infectious diseases/immunomodulation, and endocrine/metabolic. The final article selected from each clinical domain was summarized following a three-round modified Delphi process and included three randomized controlled trials and three systematic review/meta-analyses. Article topics summarized included dexmedetomidine versus other sedatives during mechanical ventilation, beta-blocker treatment in the critically ill, restriction of IV fluids in septic shock, venous thromboembolism prophylaxis in critically ill adults, duration of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia, and low-dose methylprednisolone treatment in severe community-acquired pneumonia. CONCLUSIONS This concise review provides a perspective on articles published in 2022 that are relevant to the pharmacotherapeutic care of critically ill patients and their potential impact on clinical practice.
Collapse
Affiliation(s)
- Payal K Gurnani
- Department of Pharmacy, Memorial Hermann The Woodlands Medical Center, The Woodlands, TX
| | - Brooke Barlow
- Department of Pharmacy, Memorial Hermann The Woodlands Medical Center, The Woodlands, TX
| | - Bryan Boling
- Department of Anesthesiology, Division of Critical Care Medicine, University of Kentucky, Lexington, KY
| | | | - Jose L Diaz-Gomez
- Department of Anesthesiology and Critical Care Medicine, Texas Heart Institute, Baylor College of Medicine, Houston, TX
| | - Jenna Ford
- Department of Neurology, University of Florida, Gainesville, FL
| | | | - Ashish K Khanna
- Department of Anesthesiology, Section of Critical Care Medicine, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC
| | | | | | | | - Nathan Thornton
- Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN
| | - Saraschandra Vallabhajosyula
- Department of Medicine, Section of Cardiovascular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC
| | - Corey J Witenko
- Department of Pharmacy, New York-Presbyterian Hospital, New York, NY
| | | |
Collapse
|
3
|
Wieruszewski PM, Brickett LM, Dayal L, Egan AM, Khanna AK, Lemieux SM, Mukkera SR, Patel JS, Reichert MJ, Reynolds TR, Sen P, Thornton NM, Turpin GM, Winter JB, Bissell BD. Major Publications in the Critical Care Pharmacotherapy Literature: 2021. Crit Care Explor 2022; 4:e0823. [PMID: 36567788 PMCID: PMC9760627 DOI: 10.1097/cce.0000000000000823] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
Abstract
To summarize the most impactful articles relevant to the pharmacotherapy of critically ill adult patients published in 2021. DATA SOURCE PubMed/MEDLINE. STUDY SELECTION Randomized controlled trials, prospective studies, or systematic review/meta-analyses of adult critical care patients assessing a pharmacotherapeutic intervention and reporting clinical endpoints published between January 1, 2021, and December 31, 2021. DATA EXTRACTION Candidate articles were organized by clinical domain based on the emerging themes from all studies. A modified Delphi process was applied to obtain consensus on the most impactful publication within each clinical domain based on overall contribution to scientific knowledge and novelty to the literature. DATA SYNTHESIS The search revealed 830 articles, of which 766 were excluded leaving 64 candidate articles for the Delphi process. These 64 articles were organized by clinical domain including: emergency/neurology, cardiopulmonary, nephrology/fluids, infectious diseases, metabolic, immunomodulation, and nutrition/gastroenterology. Each domain required the a priori defined three Delphi rounds. The resultant most impactful articles from each domain included five randomized controlled trials and two systematic review/meta-analyses. Topics studied included sedation during mechanical ventilation, anticoagulation in COVID-19, extended infusion beta-lactams, interleukin-6 antagonists in COVID-19, balanced crystalloid resuscitation, vitamin C/thiamine/hydrocortisone in sepsis, and promotility agents during enteral feeding. CONCLUSIONS This synoptic review provides a summary and perspective of the most impactful articles relevant to the pharmacotherapy of critically ill adults published in 2021.
Collapse
Affiliation(s)
| | | | | | - Ashley M Egan
- Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN
| | - Ashish K Khanna
- Department of Anesthesiology, Section of Critical Care Medicine, Wake Forest School of Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC
| | | | | | | | | | | | - Parijat Sen
- Division of Pulmonary and Critical Care, University of Kentucky, Lexington, KY
| | | | | | - Jessica B Winter
- UC Health, University of Cincinnati Medical Center, Cincinnati, OH
| | | |
Collapse
|
4
|
Major publications in the critical care pharmacotherapy literature: 2019. J Crit Care 2020; 62:197-205. [PMID: 33422810 DOI: 10.1016/j.jcrc.2020.12.018] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2020] [Revised: 12/07/2020] [Accepted: 12/20/2020] [Indexed: 12/11/2022]
Abstract
PURPOSE To summarize selected meta-analyses and trials related to critical care pharmacotherapy published in 2019. MATERIALS AND METHODS The Critical Care Pharmacotherapy Literature Update (CCPLU) Group screened 36 journals monthly for impactful articles and reviewed 113 articles during 2019 according to Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) criteria. RESULTS Articles with a 1A grade, including three clinical practice guidelines, six meta-analyses, and five original research trials are reviewed here from those included in the monthly CCPLU. Clinical practice guidelines on the use of polymyxins and antiarrhythmic drugs in cardiac arrest as well as meta-analyses on antipsychotic use in delirium, stress ulcer prophylaxis (SUP), and vasoactive medications in septic shock and cardiac arrest were summarized. Original research trials evaluated delirium, sedation, neuromuscular blockade, SUP, anticoagulation reversal, and hemostasis. CONCLUSION This clinical review and expert opinion provides summary and perspectives of clinical practice impact on influential critical care pharmacotherapy publications in 2019.
Collapse
|
5
|
Major publications in critical care pharmacotherapy literature in 2018. J Crit Care 2019; 52:200-207. [DOI: 10.1016/j.jcrc.2019.04.029] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2019] [Revised: 04/22/2019] [Accepted: 04/27/2019] [Indexed: 01/21/2023]
|
6
|
Hammond DA, Baumgartner L, Cooper C, Donahey E, Harris SA, Mercer JM, Morris M, Patel MK, Plewa-Rusiecki AM, Poore AA, Szaniawski R, Horner D. Major publications in the critical care pharmacotherapy literature: January-December 2017. J Crit Care 2018; 45:239-246. [PMID: 29496373 DOI: 10.1016/j.jcrc.2018.02.012] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2018] [Revised: 02/18/2018] [Accepted: 02/20/2018] [Indexed: 12/18/2022]
Abstract
PURPOSE To summarize selected meta-analyses and trials related to critical care pharmacotherapy published in 2017. The Critical Care Pharmacotherapy Literature Update (CCPLU) Group screened 32 journals monthly for impactful articles and reviewed 115 during 2017. Two meta-analyses and eight original research trials were reviewed here from those included in the monthly CCPLU. Meta-analyses on early, goal-directed therapy for septic shock and statin therapy for acute respiratory distress syndrome were summarized. Original research trials that were included evaluate thrombolytic therapy in severe stroke, hyperoxia and hypertonic saline in septic shock, intraoperative ketamine for prevention of post-operative delirium, intravenous ketorolac dosing regimens for acute pain, angiotensin II for vasodilatory shock, dabigatran reversal with idarucizumab, bivalirudin versus heparin monotherapy for myocardial infarction, and balanced crystalloids versus saline fluid resuscitation. CONCLUSION This clinical review provides perspectives on impactful critical care pharmacotherapy publications in 2017.
Collapse
Affiliation(s)
- Drayton A Hammond
- Rush University Medical Center, 1653 West Congress Parkway, Chicago, IL 60612, United States.
| | - Laura Baumgartner
- Touro University California College of Pharmacy, 1310 Club Drive, Vallejo, CA 94592, United States
| | - Craig Cooper
- Roosevelt University College of Pharmacy, 430 S. Michigan Avenue, Chicago, IL 60605, United States.
| | - Elisabeth Donahey
- Loyola University Medical Center, 2160 S 1st Avenue, Maywood, IL 60153, United States.
| | - Serena A Harris
- Eskenazi Health, 720 Eskenazi Avenue, Indianapolis, IN 46202, United States.
| | - Jessica M Mercer
- Roper St Francis Healthcare, 2095 Henry Tecklenburg Drive, Charleston, SC 29414, United States
| | - Mandy Morris
- University of California, San Francisco Medical Center, 533 Parnassus Ave., Box 0622, San Francisco, CA 94143, United States.
| | - Mona K Patel
- NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, 630 West 168th Street, NY, New York 10032, United States.
| | - Angela M Plewa-Rusiecki
- John H. Stroger, Jr. Hospital of Cook County, 1901 West Harrison Street, LL175, Chicago, IL 60612, United States.
| | - Alia A Poore
- Cleveland Clinic Fairview Hospital, 18101 Lorain Road, Cleveland, OH 44111, United States.
| | - Ryan Szaniawski
- Froedtert & the Medical College of Wisconsin - Community Memorial Hospital, W180 N8085 Town Hall Rd, Menomonee Falls, WI 53226, United States.
| | - Deanna Horner
- United Healthcare Medicare and Retirement - Part D STARs, 2655 Warrenville Road, 3rd floor, Downers Grove, IL 60515, United States.
| |
Collapse
|
7
|
Redesigning Journal Clubs to Staying Current with the Literature. PHARMACY 2017; 5:pharmacy5040062. [PMID: 29113107 PMCID: PMC5748543 DOI: 10.3390/pharmacy5040062] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2017] [Revised: 11/01/2017] [Accepted: 11/03/2017] [Indexed: 12/26/2022] Open
Abstract
Staying current with the literature is of paramount importance to the pharmacist engaged in an evidence-based clinical practice. Given the expanding roles and responsibilities of today’s pharmacists combined with exponential growth in new medical and health sciences literature, staying current has become an extremely daunting task. Traditional journal clubs have focused upon their role as a training vehicle for teaching critical reading skills to residents. However, schools of pharmacy are now required to provide instruction in biostatistics, research design, and interpretation. We present a paradigm shift in the traditional journal club model whereby a collection of periodicals is screened and a short synopsis of the pertinent articles is provided. The associated tasks for screening and presenting of the primary literature are shared among a group of clinicians and trainees with similar practice interests resulting in a more reasonable workload for the individual. This journal club method was effective in identifying a significant majority of articles judged to be pertinent by independent groups of clinicians in the same practice arenas. Details regarding the shared core practice and knowledge base elements, journal club format, identification of journals, and evaluation of the success of the journal club technique are provided.
Collapse
|